The so­ci­e­tal im­pact of early in­ten­si­fied tre­at­ment in pa­ti­ents with type 2 di­a­be­tes mel­li­tus

Journal of Comparative Effectiveness Research

A pro­cu­re­ment tool for stre­am­li­ned In­put-Out­put su­staina­bi­li­ty As­sess­ment

E3S Web of Conferences

An in­put–out­put ana­ly­sis of unit la­bour cost de­ve­lop­ments of the Ger­man ma­nu­fac­tu­ring sec­tor since the mi­d-1990s

Journal for Labour Market Research

Are me­di­ci­nes more green­hou­se gas in­ten­si­ve than cars? Com­ment to Belk­hir, L., El­me­li­gi, A., 2019: Ca­r­bon foot­print of the glo­bal phar­ma­ceu­ti­cal in­dus­try and re­la­ti­ve im­pact of its major players

Journal of Cleaner Production

The So­ci­e­tal Eco­no­mic Im­pact of Se­cu­ki­nu­mab in Fir­st‑­Li­ne Tre­at­ment of Mo­de­ra­te to Se­vere Plaque Pso­ri­a­sis in Ger­ma­ny: An Open‑­Co­hort Si­mu­la­ti­on

Expert Review of Pharmacoeconomics & Outcomes Research

So­ci­al Im­pact of Pro­phylac­tic Mi­grai­ne Tre­at­ments in Ger­ma­ny: A State-Tran­si­ti­on and Open Co­hort Ap­proach

Value in Health

A Re­view of Cur­rent Ap­proa­ches to De­fi­ning and Va­lu­ing In­no­va­ti­on in He­alth Tech­no­lo­gy As­sess­ment

Value in Health

The so­ci­e­tal im­pact of obi­nu­tu­zu­mab in the fir­st-­li­ne tre­at­ment of pa­ti­ents with fol­li­cu­lar lym­pho­ma in Ger­ma­ny

Future Medicine

The so­ci­e­tal im­pact of a bio­lo­gic tre­at­ment of an­ky­lo­sing spon­dy­li­tis: a case study based on se­cu­ki­nu­mab

Journal of Comparative Effectiveness Research

The So­cioe­co­no­mic Bur­den of Mi­grai­ne: An Eva­lua­ti­on of Pro­duc­ti­vi­ty Los­ses due to Mi­grai­ne-Head­a­ches Based on a Po­pu­la­ti­on Study in Ger­ma­ny

Cephalalgia

Bud­get im­pact ana­ly­sis of the use of oral and in­tra­ve­nous the­ra­py re­gi­mens for the tre­at­ment of re­lap­sed or re­frac­to­ry mul­ti­ple mye­lo­ma in Ger­ma­ny

European Journal of Health Economics

Cost Ef­fec­tiven­ess of Se­cu­ki­nu­mab Ver­sus Other Bio­lo­gics and Apre­mi­last in the Tre­at­ment of Ac­ti­ve Pso­ria­tic Ar­thri­tis in Ger­ma­ny

Applied Health Economics and Health Policy

A case study ap­p­ly­ing a novel ap­proach to esti­ma­te the so­ci­al im­pact of a me­di­cal in­no­va­ti­on – the use of se­cu­ki­nu­mab for pso­ria­tic ar­thri­tis in Ger­ma­ny

Expert Review of Pharmacoeconomics & Outcomes Research

The so­ci­e­tal im­pact of Ere­nu­mab in pro­phylac­tic tre­at­ment of pa­ti­ents with mi­grai­ne in Ger­ma­ny: a ma­cro­e­co­no­mic open-­co­hort ap­proach

Value in Health

Ger­man cost ana­ly­sis of tri­plet re­gi­mens for re­lap­sed or re­frac­to­ry mul­ti­ple mye­lo­ma pa­ti­ents

Value in Health

The so­ci­e­tal im­pact of Le­na­li­do­mi­de in the tre­at­ment of pa­ti­ent with mul­ti­ple mye­lo­ma in Ger­ma­ny

Value in Health